Metronomic Oral Cyclophosphamide in 2 Heavily Pretreated Patients With Metastatic Castration-resistant Prostate Cancer With Homologous Recombination Deficiency (HRD): A Case Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metronomic Oral Cyclophosphamide in 2 Heavily Pretreated Patients With Metastatic Castration-resistant Prostate Cancer With Homologous Recombination Deficiency (HRD): A Case Report

Published:2019-04 Issue:2 Volume:17 Page:157-160
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Ling Hang Huong^ORCID,Lin Yung-Chang^ORCID

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference29 articles.

1. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

2. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

3. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

4. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer;Castro;J Clin Oncol,2013

5. DNA-repair defects and olaparib in metastatic prostate cancer;Mateo;N Engl J Med,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review;Journal of Clinical Medicine;2022-05-15

2. Molecular tests for prediction of tumor sensitivity to cytotoxic drugs;Cancer Letters;2022-02

3. Docetaxel;Reactions Weekly;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP